Delivery Order SPE2DB20D1100-SPE2DB25FE1W3
- Not listed
- The Defense Logistics Agency awarded a $1,376.87 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $2,025.83 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Methylphenidate ER(LA) 20mg in quantities of 100 capsules. This is a firm fixed price, non-set-aside contract with a completion date of August 13, 2025, to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Methylphenidate ER (CD) 50mg capsules (100 count) valued at $1,716.02. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,130.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 30mg capsules (100-count units). This contract award, executed on August 4, 2025, with completion targeted for August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 30mg capsules (100-count) with a ceiling value of $1,025.98. The contract, executed on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025. This award is unset-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $1,006.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg in a quantity of 100 capsules. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER(LA) 20mg tablets (100-count units) under a firm fixed-price contract valued at $1,511.72. This is a non-set-aside competitive award with an ultimate completion date of July 29, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the vendor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,205.38 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 10mg capsules (100-count units) under a firm fixed-price contract type. This non-set-aside award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1W3Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,745.29 on August 20, 2025, for the supply of Methylphenidate ER(CD) 30mg capsules (100 count). This is a firm fixed-price, non-set-aside contract with a completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive portfolio of medications and medical supplies to military and veteran healthcare systems. The company holds a significant prime contract vehicle with the Defense Logistics Agency that enables it to furnish a broad range of pharmaceutical products, including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide. This delivery order for methylphenidate, a controlled stimulant medication commonly prescribed for attention-deficit/hyperactivity disorder, demonstrates the company's ongoing role in fulfilling routine pharmaceutical procurement needs for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/20/25 |